RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
1.270
+0.040 (3.25%)
At close: Oct 22, 2026, 4:00 PM EDT
1.251
-0.019 (-1.50%)
After-hours: Oct 22, 2026, 7:30 PM EDT
RenovoRx Revenue
RenovoRx had revenue of $909.00K in the quarter ending June 30, 2026, with 115.40% growth. This brings the company's total for the last twelve months to $1.98M, up 198.49% year-over-year. In the year 2025, RenovoRx had annual revenue of $1.12M with 2,511.63% growth. That makes RenovoRx the 42,387th largest company in the world by revenue and 5,778th in the United States.
Revenue (ttm)
$1.98M
Revenue Growth
+198.49%
P/S Ratio
29.01
Revenue / Employee
$116,235
Employees
17
Market Cap
57.31M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.12M | 1.08M | 2,511.63% |
| Dec 31, 2024 | 43.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Xilio Therapeutics | 64.09M |
| Caribou Biosciences | 10.04M |
| Alps Group | 3.74M |
| Clene | 197.00K |
| iBio, Inc. | 100.00K |
RNXT News
- 19 hours ago - RenovoRx to Report Third Quarter 2026 Financial Results and Business Highlights on November 5, 2026 - GlobeNewsWire
- 15 days ago - RenovoRx enrolls first patient in PRISM-TAMP trial - TheFly
- 15 days ago - RenovoRx Advances TAMP™ into Borderline Resectable Pancreatic Cancer with First Patient Enrolled in Investigator-Initiated PRISM-TAMP Trial - GlobeNewsWire
- 21 days ago - RenovoRx announces publication on TAMP platform’s potential - TheFly
- 21 days ago - RenovoRx Announces Peer-Reviewed Publication Highlighting the TAMP™ Platform's Potential to Improve Chemotherapeutic Delivery for Locally Advanced Pancreatic Cancer - GlobeNewsWire
- 5 weeks ago - RenovoRx Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 5 weeks ago - RenovoRx Slides: Investor presentation - Filings
- 7 weeks ago - RenovoRx to Present at H.C. Wainwright 28th Annual Global Investment Conference, September 14th-16th - GlobeNewsWire